Financials Nutritional Growth Solutions Ltd.

Equities

NGS

IL0011681116

Pharmaceuticals

Market Closed - Australian S.E. 02:10:44 2024-04-26 am EDT 5-day change 1st Jan Change
0.006 AUD 0.00% Intraday chart for Nutritional Growth Solutions Ltd. +20.00% -57.14%

Valuation

Fiscal Period: December 2020 2021 2022 2023
Capitalization 1 18.95 15.86 6.02 2.395
Enterprise Value (EV) 1 14.44 11.78 4.532 2.584
P/E ratio -2.13 x -2.88 x -1.24 x -0.64 x
Yield - - - -
Capitalization / Revenue 10.1 x 5.22 x 2.04 x 0.8 x
EV / Revenue 7.72 x 3.87 x 1.54 x 0.87 x
EV / EBITDA -6.45 x -2.54 x -1.05 x -0.85 x
EV / FCF -17,364,848 x -6,150,987 x -1,408,677 x -1,964,052 x
FCF Yield -0% -0% -0% -0%
Price to Book 4.38 x 4.09 x 2.9 x -13.5 x
Nbr of stocks (in thousands) 94,714 118,075 148,307 251,227
Reference price 2 0.2000 0.1343 0.0406 0.009534
Announcement Date 3/25/21 3/30/22 3/31/23 3/28/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 0.524 1.184 1.87 3.04 2.947 2.984
EBITDA 1 0.158 -2.103 -2.239 -4.633 -4.321 -3.048
EBIT 1 0.157 -2.112 -2.249 -4.733 -4.344 -3.071
Operating Margin 29.96% -178.38% -120.27% -155.69% -147.4% -102.92%
Earnings before Tax (EBT) 1 0.07 -2.027 -4.36 -4.78 -4.249 -2.893
Net income 1 -0.044 -2.031 -4.361 -4.78 -4.249 -2.893
Net margin -8.4% -171.54% -233.21% -157.24% -144.18% -96.95%
EPS 2 -0.001205 -0.0556 -0.0940 -0.0466 -0.0328 -0.0150
Free Cash Flow - -1.081 -0.8316 -1.915 -3.217 -1.316
FCF margin - -91.28% -44.47% -62.99% -109.17% -44.09%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 10/28/20 10/28/20 3/25/21 3/30/22 3/31/23 3/28/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - 0.19
Net Cash position 1 2.4 0.59 4.51 4.08 1.49 -
Leverage (Debt/EBITDA) - - - - - -0.062 x
Free Cash Flow - -1.08 -0.83 -1.91 -3.22 -1.32
ROE (net income / shareholders' equity) - -139% -177% -117% -143% -305%
ROA (Net income/ Total Assets) - -74.1% -46.3% -59.4% -69.9% -96.8%
Assets 1 - 2.741 9.41 8.044 6.079 2.988
Book Value Per Share 2 0.0600 0.0200 0.0500 0.0300 0.0100 -0
Cash Flow per Share 2 0.0700 0.0200 0.0500 0.0400 0.0100 0
Capex 1 0.01 0.02 0.01 0 0 -
Capex / Sales 2.48% 1.27% 0.27% 0.13% 0.14% -
Announcement Date 10/28/20 10/28/20 3/25/21 3/30/22 3/31/23 3/28/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. NGS Stock
  4. Financials Nutritional Growth Solutions Ltd.